• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在 COVID-19 大流行期间的住院糖尿病患者管理的务实方法。

A Pragmatic Approach to Inpatient Diabetes Management during the COVID-19 Pandemic.

机构信息

University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

University of Pittsburgh Medical Center Shadyside Hospital, Omaha, NE.

出版信息

J Clin Endocrinol Metab. 2020 Sep 1;105(9). doi: 10.1210/clinem/dgaa342.

DOI:10.1210/clinem/dgaa342
PMID:32498085
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7313952/
Abstract

The pandemic of COVID-19 has presented new challenges to hospital personnel providing care for infected patients with diabetes who represent more than 20% of critically ill patients in intensive care units. Appropriate glycemic management contributes to a reduction in adverse clinical outcomes in acute illness but also requires intensive patient interactions for bedside glucose monitoring, intravenous and subcutaneous insulin administration, as well as rapid intervention for hypoglycemia events. These tasks are required at a time when minimizing patient interactions is recommended as a way of avoiding prolonged exposure to COVID-19 by health care personnel who often practice in settings with limited supplies of personal protective equipment. The purpose of this manuscript is to provide guidance for clinicians for reconciling recommended standards of care for infected hospitalized patients with diabetes while also addressing the daily realities of an overwhelmed health care system in many areas of the country. The use of modified protocols for insulin administration, bedside glucose monitoring, and medications such as glucocorticoids and hydroxychloroquine that may affect glycemic control are discussed. Continuous glucose monitoring systems have been proposed as an option for reducing time spent with patients, but there are important issues that need to be addressed if these are used in hospitalized patients. On-site and remote glucose management teams have potential to provide guidance in areas where there are shortages of personnel who have expertise in inpatient glycemic management.

摘要

COVID-19 大流行给为感染糖尿病的患者提供护理的医院人员带来了新的挑战,这些患者占重症监护病房中危重症患者的 20%以上。适当的血糖管理有助于减少急性疾病的不良临床结局,但也需要对患者进行密集的互动,以进行床边血糖监测、静脉和皮下胰岛素给药,以及快速干预低血糖事件。这些任务是在建议尽量减少患者互动的时候需要完成的,这是避免医护人员长时间接触 COVID-19 的一种方式,因为他们经常在个人防护设备供应有限的环境中工作。本文的目的是为临床医生提供指导,在协调感染住院糖尿病患者的推荐护理标准的同时,应对该国许多地区医疗系统不堪重负的日常现实。讨论了修改后的胰岛素给药、床边血糖监测以及可能影响血糖控制的药物(如皮质类固醇和羟氯喹)的使用。连续血糖监测系统被提议作为减少与患者在一起时间的一种选择,但如果在住院患者中使用这些系统,需要解决一些重要问题。现场和远程血糖管理团队有可能在人员短缺且在住院患者血糖管理方面具有专业知识的地区提供指导。

相似文献

1
A Pragmatic Approach to Inpatient Diabetes Management during the COVID-19 Pandemic.在 COVID-19 大流行期间的住院糖尿病患者管理的务实方法。
J Clin Endocrinol Metab. 2020 Sep 1;105(9). doi: 10.1210/clinem/dgaa342.
2
Individualizing Inpatient Diabetes Management During the Coronavirus Disease 2019 Pandemic.2019年冠状病毒病大流行期间的住院糖尿病个体化管理
J Diabetes Sci Technol. 2020 Jul;14(4):705-707. doi: 10.1177/1932296820923045. Epub 2020 May 5.
3
Issues for the management of people with diabetes and COVID-19 in ICU.ICU 中合并 COVID-19 的糖尿病患者的管理问题。
Cardiovasc Diabetol. 2020 Jul 20;19(1):114. doi: 10.1186/s12933-020-01089-2.
4
Continuous Glucose Monitoring in Critically Ill Patients With COVID-19: Results of an Emergent Pilot Study.2019冠状病毒病危重症患者的持续血糖监测:一项紧急初步研究的结果
J Diabetes Sci Technol. 2020 Nov;14(6):1065-1073. doi: 10.1177/1932296820964264. Epub 2020 Oct 16.
5
Hospital Diabetes Meeting 2020.2020年医院糖尿病会议
J Diabetes Sci Technol. 2020 Sep;14(5):928-944. doi: 10.1177/1932296820939626. Epub 2020 Aug 12.
6
How diabetes management is adapting amid the COVID-19 pandemic.在新冠疫情期间糖尿病管理是如何进行调整的。
Lancet Diabetes Endocrinol. 2020 Jul;8(7):571. doi: 10.1016/S2213-8587(20)30181-9. Epub 2020 May 15.
7
Diabetes mellitus and COVID-19: A review and management guidance for South Africa.糖尿病与 COVID-19:南非的综述及管理指导。
S Afr Med J. 2020 Jun 18;110(8):761-766.
8
COVID-19 issues related to pediatric neuropsychology and inpatient rehabilitation - challenges to usual care and solutions during the pandemic.COVID-19 相关儿科神经心理学和住院康复问题 - 大流行期间常规护理的挑战和解决方案。
Clin Neuropsychol. 2020 Oct-Nov;34(7-8):1380-1394. doi: 10.1080/13854046.2020.1811892. Epub 2020 Aug 26.
9
Guidelines for the management of diabetes services and patients during the COVID-19 pandemic.COVID-19 大流行期间糖尿病服务和患者管理指南。
Diabet Med. 2020 Jul;37(7):1087-1089. doi: 10.1111/dme.14316. Epub 2020 May 17.
10
COVID-19: decision making and palliative care.COVID-19:决策与姑息治疗。
Swiss Med Wkly. 2020 Mar 24;150:w20233. doi: 10.4414/smw.2020.20233. eCollection 2020 Mar 23.

引用本文的文献

1
Post-COVID Metabolic Fallout: A Growing Threat of New-Onset and Exacerbated Diabetes.新冠后代谢后遗症:新发和加重型糖尿病的威胁日益增加。
Biomedicines. 2025 Jun 16;13(6):1482. doi: 10.3390/biomedicines13061482.
2
Covid 19 and diabetes in children: advances and strategies.儿童新冠病毒感染与糖尿病:进展与策略
Diabetol Metab Syndr. 2024 Jan 29;16(1):28. doi: 10.1186/s13098-024-01267-2.
3
Pediatric Diabetes and Diabetic Ketoacidosis After COVID-19: Challenges Faced and Lessons Learnt.新冠疫情后的儿童糖尿病与糖尿病酮症酸中毒:面临的挑战与经验教训
Pediatric Health Med Ther. 2023 Sep 4;14:281-288. doi: 10.2147/PHMT.S384104. eCollection 2023.
4
Molecular Mechanisms Responsible for Diabetogenic Effects of COVID-19 Infection-Induction of Autoimmune Dysregulation and Metabolic Disturbances.导致 COVID-19 感染引发自身免疫失调和代谢紊乱的致糖尿病作用的分子机制。
Int J Mol Sci. 2023 Jul 18;24(14):11576. doi: 10.3390/ijms241411576.
5
Characteristics, Mortality, and Clinical Outcomes of Hospitalized Patients with COVID-19 and Diabetes: A Reference Single-Center Cohort Study from Poland.COVID-19合并糖尿病住院患者的特征、死亡率及临床结局:一项来自波兰的单中心队列参考研究
Int J Endocrinol. 2023 Feb 16;2023:8700302. doi: 10.1155/2023/8700302. eCollection 2023.
6
Glycemic control using intermittently scanned continuous glucose monitoring in patients with diabetes requiring methylprednisolone therapy for severe COVID-19.在需要甲基强的松龙治疗重症 COVID-19 的糖尿病患者中,使用间歇性扫描式连续血糖监测进行血糖控制。
Glob Health Med. 2022 Dec 31;4(6):336-340. doi: 10.35772/ghm.2022.01053.
7
Dexamethasone use and insulin requirements in coronovirus-19 (COVID-19) infection stratified by Hemoglobin A1c.按糖化血红蛋白分层的冠状病毒病19(COVID-19)感染中地塞米松的使用情况及胰岛素需求
Diabet Epidemiol Manag. 2023 Apr-Jun;10:100123. doi: 10.1016/j.deman.2022.100123. Epub 2022 Dec 9.
8
16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2023.16. 医院中的糖尿病护理:2023 年糖尿病护理标准。
Diabetes Care. 2023 Jan 1;46(Suppl 1):S267-S278. doi: 10.2337/dc23-S016.
9
Covid-19 infection in children and adolescents and its association with type 1 diabetes mellitus (T1d) presentation and management.儿童和青少年感染 COVID-19 及其与 1 型糖尿病 (T1d) 发病和治疗的关系。
Endocrine. 2023 May;80(2):237-252. doi: 10.1007/s12020-022-03266-7. Epub 2022 Dec 3.
10
Obesity, Diabetes Mellitus, and Metabolic Syndrome: Review in the Era of COVID-19.肥胖、糖尿病和代谢综合征:COVID-19时代的综述
Clin Nutr Res. 2022 Oct 24;11(4):331-346. doi: 10.7762/cnr.2022.11.4.331. eCollection 2022 Oct.